OBJECTIVE: We examined the overall mortality rates of 1599 workers employed between 1969 and 1988 at a New Zealand site, which manufactured trichlorophenol. METHODS: We developed exposure estimates for 2,3,7,8-tetrachlorodibenzo-p-dioxin from a serum dioxin evaluation and used standardized mortality ratios (SMR) and proportional hazards models to evaluate risk from exposure. RESULTS: Among exposed workers, deaths from total cancers (SMR = 1.1, 95% confidence intervals [CI]: 0.9-1.4), non-Hodgkin lymphoma (SMR = 1.6, 95% CI: 03-4.7), and ischemic heart disease (SMR = 1.1, 95% CI: 0.9-1.5) were slightly greater than expected, whereas deaths from lung cancer (SMR = 0.8, 95% CI: 0.4-1.5) were less than expected. We observed no significant trends with exposure levels. CONCLUSIONS: Although this study is small, we found no increasing trend of cancer or disease risk with increasing 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure with the possible exception of all cancers combined.
OBJECTIVE: We examined the overall mortality rates of 1599 workers employed between 1969 and 1988 at a New Zealand site, which manufactured trichlorophenol. METHODS: We developed exposure estimates for 2,3,7,8-tetrachlorodibenzo-p-dioxin from a serum dioxin evaluation and used standardized mortality ratios (SMR) and proportional hazards models to evaluate risk from exposure. RESULTS: Among exposed workers, deaths from total cancers (SMR = 1.1, 95% confidence intervals [CI]: 0.9-1.4), non-Hodgkin lymphoma (SMR = 1.6, 95% CI: 03-4.7), and ischemic heart disease (SMR = 1.1, 95% CI: 0.9-1.5) were slightly greater than expected, whereas deaths from lung cancer (SMR = 0.8, 95% CI: 0.4-1.5) were less than expected. We observed no significant trends with exposure levels. CONCLUSIONS: Although this study is small, we found no increasing trend of cancer or disease risk with increasing 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure with the possible exception of all cancers combined.
Authors: Anjoeka Pronk; John R Nuckols; Anneclaire J De Roos; Matthew Airola; Joanne S Colt; James R Cerhan; Lindsay Morton; Wendy Cozen; Richard Severson; Aaron Blair; David Cleverly; Mary H Ward Journal: Environ Health Date: 2013-02-22 Impact factor: 5.984
Authors: Michael Goodman; K M Venkat Narayan; Dana Flanders; Ellen T Chang; Hans-Olov Adami; Paolo Boffetta; Jack S Mandel Journal: Am J Epidemiol Date: 2015-03-01 Impact factor: 4.897
Authors: David I McBride; James J Collins; Thomas John Bender; Kenneth M Bodner; Lesa L Aylward Journal: BMJ Open Date: 2018-10-17 Impact factor: 2.692